Core Viewpoint - The approval process for seven products from Kunming Blood Products has progressed to the comprehensive review and final approval stage, raising questions about the timeline for production post-approval [1] Group 1: Company Updates - Tian Tan Bio (600161.SH) confirmed that the Yunnan project has completed the on-site verification of major product registrations and GMP compliance inspections [1] - The company is currently addressing inspection deficiencies and is proceeding with the review of the registered products according to the registration progress [1] - Tian Tan Bio plans to actively communicate with government departments to expedite the transfer of production sites for major products related to the Shanghai Yunnan project [1]